WCI
검색
Login
Sign Up
Sitemap
About Us
Message from the President
Mission
History
Charter
Bylaws
Organization
Linkage with other organizations
Membership
Membership
Organization Members
Individual Members
Student Members
Honorary Members
ICI
ICI History
ICI Chronicles
ICI Documents
ICI Photos
Publications
Newsletters
Brochures
Annual Activity Reports
Minutes
Training /
Seminar
Training Courses
Materials
Communication
Announcements
Events
RI Related News
RI Related News
Awards
Awards
Winners
Funding
Kinds of WCI funding
Acknowledgements
Community
RI Related News
RI Related News
Home > RI Related News > RI Related News
RI Related News
LOGIN
게시글 목록
No
TItle
Name
Date
Hit
730
KHNP Promoting Commercialization of Unused Tritium
WCI Secretariat
2022/06/02
32
729
Convergent Therapeutics and IONETIX Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
WCI Secretariat
2022/06/02
34
728
IONETIX and ATONCO Sign a Partnership Agreement to Fight Bladder Cancer
WCI Secretariat
2022/06/02
34
727
IONETIX Partners with CIRA to Bring N-13 Ammonia to South Florida
WCI Secretariat
2022/06/02
38
726
Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer
WCI Secretariat
2022/06/02
25
725
Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients
WCI Secretariat
2022/06/02
24
724
Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Cancer
WCI Secretariat
2022/06/02
29
723
Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
WCI Secretariat
2022/06/02
32
722
Facility for Rare Isotope Beams opens its doors to Discovery
WCI Secretariat
2022/06/02
36
721
Laurentis is Helping Meet Global Demands by Increasing He-3 Production
WCI Secretariat
2022/06/02
37
720
CNNC Begins Production of carbon-14 at Qinshan reactor
WCI Secretariat
2022/06/02
36
719
QSAM Biosciences Doses First Patient in its Clinical Trial for Cyclosam®, Radiopharmaceutical Drug Candidate for the Treatment of Bone Cancer
WCI Secretariat
2022/06/02
33
718
POINT Biopharma Unveils FRONTIER: A Pan-Cancer FAP-α Targeted Clinical Program
WCI Secretariat
2022/06/02
34
717
First European Union Patient Dosed with 177Lu-PNT2002 in the Phase 3 SPLASH Trial
WCI Secretariat
2022/06/02
47
716
QSAM Biosciences Receives Japanese Patent for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam®
WCI Secretariat
2022/05/04
66
First
Prev
1
2
3
4
5
6
7
8
9
10
Next
End (49 Page)
Name
Title
Contents
비밀글입니다!
글작성시 입력했던 비밀번호를 입력해주세요.
비밀번호 입력